Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2008 / Cilt: 48 - Sayı: 2

ğhotodynamic therapy with verteporfin in subfoveal choroidal neovascular mambranes due to age related macular degeneration

Yaşa bağlı maküla dejenerasyonunda subfoveal koroidal neovasküler membranların verteporfin ile fotodinamik tedavisi

Pages
85–90
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Photodynamic therapy with verteporfin is effective and successful in preserving visual acuity in subfoveal choroidal neovascular membranes due to age related macular degeneration.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the results of photodynamic therapy (PDT) with verteporfin in subfoveal choroidal neovascular membranes due to age related macular degeneration.
📊
Key Findings & Data:Materials and methods: Sixty eyes of 50 patients who had photodynamic therapy with verteporfin (Visudyne ® Novartis-Switzerland)for subfoveal choroidal neovascular membrane between April 2005 and May 2007 at Haydarpafla Numune Training and Research Hospital, Eye Clinic 2 were included in this study.
💡
Conclusion & Impact:Conclusion: Photodynamic therapy with verteporfin is effective and successful in preserving visual acuity in subfoveal choroidal neovascular membranes due to age related macular degeneration.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the results of photodynamic therapy (PDT) with verteporfin in subfoveal choroidal neovascular membranes due to age related macular degeneration. Materials and methods: Sixty eyes of 50 patients who had photodynamic therapy with verteporfin (Visudyne ® Novartis-Switzerland)for subfoveal choroidal neovascular membrane between April 2005 and May 2007 at Haydarpafla Numune Training and Research Hospital, Eye Clinic 2 were included in this study. Initial and last best corrected visual acuities were examined with Early Treatment Diabetic Retinopathy Study (ETDRS) chart. Ophthalmic examination and fundus fluorescein angiography (FFA) findings were recorded. Cases were divided into three groups as predominantly classic, minimally classic and occult choroidal neovascular membranes on the basis of fundus fluorescein angiography findings. After the therapy cases were controlled at first and third months and then at three month intervals. Fortyfour eyes had 1, 3 eyes had 2, 4 eyes had 3,5 eyes had 4 and 4 eyes had 5 times photodynamic therapy. Results: Mean age of the patients included in the study was 68.6±8.12 years. Twenty seven of 50 patients were female (54%), 23 were male (46%). According to the FFA findings 30 (50%) cases had predominantly classic, 11 (18.3%) cases had minimally classic and 19 (31.7%) cases had occult choroidal neovascular membranes. According to logMAR mean initial best corrected visual acuities were 0.84±0.38 (0.30- 1.80). Acoording to logMAR mean final best corrected visual acuities were 0.78±0.46 (0.10-1.60). There were no statistically siginificant differences among the changes of mean visula acuity according to lesion types (p>0.05). There was a statistically significant positive correlation between the initial and final best corrected visual acuities. Conclusion: Photodynamic therapy with verteporfin is effective and successful in preserving visual acuity in subfoveal choroidal neovascular membranes due to age related macular degeneration.

Özet

Amaç: Yaşa balı makula dejenerasyonu sonucu gelişen subfoveal koroidal neovaskuler membranların verteporfin ile fotodinamik tedavi (PDT) sonuclarını deerlendirmek. Gereç ve Yöntem: Haydarpaşa Numune Eitim ve Araştırma Hastanesi 2.Goz Klinii’nde Nisan 2005- Mayıs 2007 tarihleri arasında verteporfin (VisudyneR Novartis-‹svicre) ile fotodinamik tedavi uygulanan, yaşa balı subfoveal koroidal neovaskuler membranı olan 50 hastanın 60 gozu calışmaya dahil edildi. Olguları n başlangıc ve sonuc en iyi gorme keskinlikleri Early Treatment Diabetic Retinopathy Study (ETDRS) eşeli ile alındı. Oftalmolojik muayene ve fundus şoresein anjiografi (FFA) bulguları kayıt edildi. Olgular anjiografi bulgularına gore baskın klasik, minimal klasik ve gizli koroidal neovaskuler membran olarak uc gruba ayrıldı. Tedavi sonrası olgular birinci ve ucuncu aylarda, daha sonraki takiplerde ise ucer ay aralarla kontrollere alındı. Kırkdort goze 1 kez, 3 goze 2 kez, 4 goze 3 kez, 5 goze 4 kez ve 4 goze de 5 kez fotodinamik tedavi uygulandı. Bulgular: Calışmaya dahil edilen hastaların yaş ortalamaları 68.6 }8.12 yıl idi. Elli hastanın 27’si (%54) kadı n, 23’u (%46) erkekti. FFA bulgularına gore olguları n 30’u (%50) baskın klasik, 11’i (%18.3) minimal klasik ve 19’u (%31.7) gizli koroidal neovaskuler membran ozelliindeydi. Başlangıc ortalama en iyi gorme keskinlikleri (E‹GK) logMAR’a gore 0.84 }0.38 idi (0.30- 1.80). Tedavi sonrası E‹GK logMAR’a gore 0.78 }0.46 idi(0.10-1.60). Lezyon tiplerine gore ilk ve son gorme keskinlikleri arasında istatistiksel olarak anlamlı farklılık gorulmedi (p>0.05). Başlangıc E‹GK ile sonuc E‹GK arasında istatistiksel olarak pozitif yonde anlamlı ilişki bulundu. Sonuç: Yaşa balı makula dejenerasyonu (YBMD) zemininde gelişen subfoveal koroidal neovaskuler membranların verteporfin ile fotodinamik tedavisi gorme keskinliinin korunmasında etkili ve başarılı bir tedavi seceneidir.

🔖

Cite This Article

TORUN, B., BAHADIR, A., ACAR, S. (2022). ğhotodynamic therapy with verteporfin in subfoveal choroidal neovascular mambranes due to age related macular degeneration. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 48 - Sayı: 2, 85–90. https://ajindex.com/articles/535538

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study Monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980;24(Suppl.):335-610
  2. Klein R, Klein BE, Jensen SC, Meuer SM. The 5 year incidence and progression of age related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7-21
  3. Rahmani B, Tielsch JM, Katz J, et al. The cause specific prevalence of visual impairment in an urban population - the Baltimore Eye Survey. Ophthalmology. 1996;103:1721-6
  4. Gass JDM. Stereoscopic atlas of macular diseases; diagnosis and treatment, 4th edn. St Louis: CV Mosby; 1997:70-2. 5.Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neavascularisation in age-related macular degeneration with verteporfin. One-year result of 2 randomized clinical trials-TAP Report 1. Arch Ophthalmol 1999; 117: 1329-1345
  5. Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H. Photodynamic effects on choroidal neovascularisation and physiological choroid. Invest Ophthalmol Vis Sci 2002;43:830-41
  6. TAP Study Group. Photodynamic Therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials – TAP Report 2. Arch Ophthalmol 2001; 119: 198-207
  7. TAP Study Group. Verteporfin Therapy for subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Three-year results of an open label extension of 2 randomized clinical trials – TAP Report 5. Arch Ophthalmol 2002;120:1307-1314
  8. Verteporfin in Photodynamic Study Group. Verteporfin therapy of subfoveal choroidal neovascularisation in Age Related Macular Degeneration: two year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularisation- Verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-60
  9. Young RW. Pathophysiology of age-related macular degeneration. Surv. Opthalmol. 1987;31:291-306. 11). Klein R, Klein BE, Jensen SC, Meuer SM. The 5 year incidence and progression of age related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7-21
  10. Olsen TW, Feng X, Kasper TJ, Rath PP, Steuer ER. Flourescein Angiographic Lesion Type Frequency in Neovascular Age-Related M